Current trials suggest MDMA could used to treat psychiatric disorders as a prescription medicine by 2021. But there remain a number of unresolved patient / doctor issues to be considered.
- Principal Research Fellow, University of Melbourne; Head of Substance Use Research, Orygen, The University of Melbourne
Contact Gillinder for
- General
- Media request
- Speaking request
- Research collaboration
- Research supervision
- Location: Melbourne, Australia
- X (formerly Twitter): @gillbedi
- Article Feed
- ORCID
- Joined
